KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Emergent BioSolutions (EBS) Receivables Refunds: 2010-2020

Historic Receivables Refunds for Emergent BioSolutions (EBS) over the last 8 years, with Mar 2020 value amounting to $10.2 million.

  • Emergent BioSolutions' Receivables Refunds was N/A to $10.2 million in Q1 2020 from the same period last year, while for Mar 2020 it was $10.2 million, marking a year-over-year change of. This contributed to the annual value of $4.6 million for FY2019, which is 46.51% down from last year.
  • As of Q1 2020, Emergent BioSolutions' Receivables Refunds stood at $10.2 million, which was up 121.74% from $4.6 million recorded in Q4 2019.
  • Emergent BioSolutions' 5-year Receivables Refunds high stood at $11.8 million for Q3 2016, and its period low was $2.4 million during Q4 2017.
  • For the 3-year period, Emergent BioSolutions' Receivables Refunds averaged around $7.6 million, with its median value being $7.8 million (2018).
  • Its Receivables Refunds has fluctuated over the past 5 years, first plummeted by 77.85% in 2016, then spiked by 258.33% in 2018.
  • Over the past 5 years, Emergent BioSolutions' Receivables Refunds (Quarterly) stood at $10.0 million in 2016, then tumbled by 75.99% to $2.4 million in 2017, then skyrocketed by 258.33% to $8.6 million in 2018, then plummeted by 46.51% to $4.6 million in 2019, then reached $10.2 million in 2020.
  • Its Receivables Refunds was $10.2 million in Q1 2020, compared to $4.6 million in Q4 2019 and $8.6 million in Q4 2018.